James analyst Gary Nachman maintained an Outperform rating on AbbVie stock (NYSE:ABBV) with a $218.00 price target. The ...
Titan Intech Ltd. key Products/Revenue Segments include I T Enabled Services for the year ending 31-Mar-2024.For the quarter ended 30-09-2024, the company has reported a Standalone Total Income of Rs ...